Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for OAB in Parkinson's with Cognitive Impairment
NCT02536976Phase 4Completed
- Sponsor
- HealthPartners Institute
- Start
- Dec 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in overactive bladder (OAB), sponsored by HealthPartners Institute. Started Dec 2015; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02536976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536976.